Key result
Severe preeclampsia was associated with elevated sST2 concentrations before delivery compared to healthy controls (p=0.04), which correlated with impaired left ventricular diastolic function.
Why the study?
The study aimed to compare soluble-ST2 concentrations in patients with severe preeclampsia versus healthy controls before and 1 year after delivery, and assess correlations with myocardial function.
Are soluble-ST2 concentrations elevated in severe preeclampsia and do they correlate with echocardiographic parameters of myocardial dysfunction?
Observational (n=53)
Are soluble-ST2 concentrations elevated in severe preeclampsia and do they correlate with echocardiographic parameters of myocardial dysfunction?
p-value: p=0.04
In women with severe preeclampsia, elevated sST2 levels correlate with echocardiographic signs of diastolic dysfunction and normalize within one year postpartum.
Elevated sST2 in severe preeclampsia may flag subclinical myocardial dysfunction; leaves open prospective validation for postpartum CV risk stratification.
Objectives: To compare soluble-ST2 (sST2) concentrations in patients with severe features of preeclampsia and healthy pregnant controls before as well as 1 year after delivery. Another objective was to assess potential correlation between sST2 concentrations and myocardial function.Methods: Patients with singleton pregnancy complicated by severe features of preeclampsia and healthy controls were included in a prospective observational study. Plasma sST2 concentrations were measured within 24 h before delivery and 1 year after delivery. Standard two-dimensional and Doppler echocardiography was performed at the time of first sST2 measurement before delivery. Mann–Whitney U test was used to compare sST2 values in preeclamptic patients versus controls. Kendall’s tau was used to assess correlation between sST2 values and echocardiographic measures of left ventricular systolic and diastolic function (p < .05 significant).Results: We included 24 patients with severe preeclampsia and 29 controls. One year after delivery, sST2 concentrations were available for 24 (45%) participants (13 in preeclampsia group and 11 controls). Concentrations of sST2 were markedly elevated in patients with severe preeclampsia compared to healthy controls before delivery (p = .04), but not 1 year after delivery (p = .80). There was no significant correlation between sST2 and parameters of systolic function. In preeclamptic patients, we found a significant inverse correlation between sST2 and markers of diastolic function: peak early mitral inflow velocity E (Kendall’s tau = −0.40; p = .02), peak early diastolic myocardial velocities at septal and lateral mitral annulus (e’) (Kendall’s tau = −0.354, p = .04) and ratio between e’ and peak systolic myocardial velocities at the septal and lateral mitral annulus (e'/s') (Kendall’s tau = −0.362, p = .04).Conclusions: Preeclampsia with severe features is associated with increased maternal plasma concentrations of sST2, which return to normal values in the first year after delivery. Higher sST2 levels in preeclamptic patients correlate with impaired parameters of left ventricular diastolic function.
No takes yet. Share an insight, caveat, or question.
Mugerli et al. (2019) conducted an observational in Preeclampsia (n=53). Severe preeclampsia vs. Healthy pregnant controls was evaluated on sST2 concentrations before delivery (p=0.04). Severe preeclampsia was associated with elevated sST2 concentrations before delivery compared to healthy controls (p=0.04), which correlated with impaired left ventricular diastolic function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: